2014 Highlights of ASH in North America Meeting

Emerging effective treatment options for salvage therapy in Hodgkin lymphoma were described by Anas Younes, MD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, New York, at th...

myelodysplastic syndromes

Caroline Helwick / May 15, 2014 / 2014 Highlights of ASH in North America Meeting

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Most recent advances in the management of myelodysplastic syndrome (MDS) are in the area of genetics, according to Steven Gore, MD, of Yale University School of Medicine, New Haven. “New genomics res...

Aug

Today In Oncology

Early-Phase Study Finds Vitamin C May Activate TET2 Function

Comparison of Screening Recommendations for Mammography

Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism

Adjuvant Temozolomide in 1p/19q Non-Codeleted Anaplastic Glioma

AKT Inhibitor Ipatasertib in Metastatic Triple-Negative Breast Cancer

2014 Highlights of ASH in North America Meeting

Better Options Emerging for Salvage Therapy in Hodgkin Lymphoma

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Early-Phase Study Finds Vitamin C May Activate TET2 Function

Comparison of Screening Recommendations for Mammography

Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism

Adjuvant Temozolomide in 1p/19q Non-Codeleted Anaplastic Glioma

AKT Inhibitor Ipatasertib in Metastatic Triple-Negative Breast Cancer

Liquid Biopsies Identify Distinct Genomic Profiles With Potentially Targetable Alterations in Carcinoma of Unknown Primary

Detection of Early-Stage Cancers With Circulating Tumor DNA

Arsenic Trioxide and Reduced Anthracycline Dose in Pediatric Acute Promyelocytic Leukemia

FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer

First-Line Cabazitaxel vs Docetaxel in Metastatic Castration-Resistant Prostate Cancer

Partial-Breast and Reduced-Dose Radiotherapy After Breast-Conserving Surgery

Searching for Happiness

ASCO Guideline on Stage IV NSCLC Therapy Updated

KEYNOTE-010 Update Shows ‘Striking’ Durability of Second-Line Pembrolizumab in NSCLC

Surveillance Mammography by Life Expectancy in Older Breast Cancer Survivors

Final Overall Survival Results of GOG 240 Trial Adding Bevacizumab to Chemotherapy in Advanced Cervical Cancer

Genomic Characteristics and Immune Infiltration in Triple-Negative Breast Cancer

CheckMate-214: Nivolumab and Ipilimumab in Intermediate- and Poor-Risk Previously Untreated Advanced or Metastatic RCC